CN109420214A - A kind of automatic pipetting systems of syringe - Google Patents
A kind of automatic pipetting systems of syringe Download PDFInfo
- Publication number
- CN109420214A CN109420214A CN201710733249.7A CN201710733249A CN109420214A CN 109420214 A CN109420214 A CN 109420214A CN 201710733249 A CN201710733249 A CN 201710733249A CN 109420214 A CN109420214 A CN 109420214A
- Authority
- CN
- China
- Prior art keywords
- syringe
- imbibition
- stage
- preferred
- drain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14212—Pumping with an aspiration and an expulsion action
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/007—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media
Abstract
The present invention discloses a kind of automatic pipetting systems of syringe, pipetting systems, it is divided into two stage systems, first stage emptying system is: using key or touch screen, start-up loading function, syringe start imbibition, when institute's liquid absorption amount is equal to the automatic imbibition capacity V of early-stage preparations section sets, syringe stops imbibition, waiting time NOs,NOThe preferred 0.5-3s of s, then starts drain, judges whether there is air in syringe, if stopping drain, then waiting time N without air in syringe1S, N1The preferred 0.5-3s of s；The second stage quantitative system is: syringe imbibition, measures V1 plus redundancy when the liquid measure sucked in syringe reaches metering needed for preset targeted injection, redundancy measures the preferred 5-20ml of V1, and syringe stops imbibition, waits N2s,N2S preferred 3-8s after waiting, starts drain, and discharge redundancy measures V1, until liquid measure is equal to metering needed for targeted injection in syringe, then stops drain.The present invention its design is scientific and reasonable, it is easy to use.
Description
Technical field:
The present invention relates to a kind of automatic pipetting systems of syringe, belong to high pressure injector technical field.
Background technique:
For patient when doing CT scan, the image effect to make is apparent, generally requires to people's internal injection contrast agent.
Since contrast agent is more sticky, in injection, generally requires and carry out imbibition by high pressure injector and inject.Existing high-pressure injection
Device generally requires artificial repeatedly imbibition drain, in imbibition to ensure in syringe without air.It is time-consuming and laborious.
Summary of the invention:
The present invention is directed to technical problems to be solved, the invention proposes a kind of automatic pipetting systems of syringe, first root
According to medicine equipment is inhaled, when determining the automatic imbibition of first stage imbibition capacity syringe, first stage imbibition capacity is first sucked, so
After be discharged, it is ensured that without air in syringe, then carry out second of imbibition；Appearance of the capacity of second of imbibition than goal-selling
It measures more, after the completion of imbibition, stops several seconds, then liquid redundancy capacity is discharged again, stablize liquid capacity in syringe
On goal-selling, design is scientific and reasonable, easy to use.
A kind of automatic pipetting systems of syringe comprising: early-stage preparations system and suction medicine system, the early-stage preparations system
System sets different automatic imbibition capacity V mainly according to the difference for inhaling medicine equipment, such as tubular type medicine absorber is preferably automated
V is between 20-40ml for imbibition capacity, and the preferred capacity of pricker imbibition is between 5-15ml；The pipetting systems are divided into two
Stage system, first stage are emptying systems, and second stage is quantitative system.
Further, the first stage emptying system is: using key or touch screen, start-up loading function, injection
Device starts imbibition, and when institute's liquid absorption amount is equal to the automatic imbibition capacity V of early-stage preparations section sets, syringe stops imbibition,
Waiting time NOs,NOThe preferred 0.5-3s of s, then starts drain, judges whether there is air in syringe, if be not in syringe free
Gas then stops drain, then waiting time N1S, N1The preferred 0.5-3s of s, first stage terminate；
Further, the second stage quantitative system is: syringe imbibition, when the liquid measure sucked in syringe reaches default
Targeted injection needed for metering plus redundancy measure V1, redundancy measure the preferred 5-20ml of V1, syringe stop imbibition, wait N2s,
N2After the preferred 3-8s. of s is waited, start drain, discharge redundancy measures V1, until liquid measure is equal to needed for targeted injection in syringe
Metering, then stops drain, and automatic load terminates.
Beneficial effects of the present invention: its elder generation of the invention determines first stage imbibition capacity syringe according to medicine equipment is inhaled
When automatic imbibition, first stage imbibition capacity is first sucked, is then discharged out, it is ensured that without air in syringe, then carry out second
Secondary imbibition；The capacity of second of imbibition is more more than the capacity of goal-selling, after the completion of imbibition, stops several seconds, then again will
The discharge of liquid redundancy capacity stablizes the liquid capacity in syringe on goal-selling, and design is scientific and reasonable, easy to use.
Detailed description of the invention:
Detailed description will be given by the following detailed implementation and drawings by the present invention for ease of explanation,.
Fig. 1 is suction medicine systematic schematic diagram of the invention；
Fig. 2 is early-stage preparations systematic schematic diagram of the invention.
Specific embodiment:
In order to make the objectives, technical solutions and advantages of the present invention clearer, below by shown in the accompanying drawings specific
Embodiment describes the present invention.However, it should be understood that these descriptions are merely illustrative, and it is not intended to limit model of the invention
It encloses.In addition, in the following description, descriptions of well-known structures and technologies are omitted, it is of the invention to avoid unnecessarily obscuring
Concept.
As shown in Figure 1 and Figure 2, the automatic pipetting systems of a kind of syringe comprising: early-stage preparations system and suction medicine system, institute
Early-stage preparations system is stated, mainly according to the difference for inhaling medicine equipment, sets different automatic imbibition capacity V, such as tubular type is inhaled
The preferably automated imbibition capacity V of medicine device is between 20-40ml, and the preferred capacity of pricker imbibition is between 5-15ml；The imbibition
System is divided into two stage systems, and the first stage is emptying system, and second stage is quantitative system.
Specifically, the first stage emptying system is: using key or touch screen, start-up loading function, injection
Device starts imbibition, and when institute's liquid absorption amount is equal to the automatic imbibition capacity V of early-stage preparations section sets, syringe stops imbibition,
Waiting time NOs,NOThe preferred 0.5-3s of s, then starts drain, judges whether there is air in syringe, if be not in syringe free
Gas then stops drain, then waiting time N1S, N1The preferred 0.5-3s of s, first stage terminate；The second stage is quantitatively
System is: syringe imbibition, measures V1 plus redundancy when the liquid measure sucked in syringe reaches metering needed for preset targeted injection, superfluous
The preferred 5-20ml of remaining metering V1, syringe stop imbibition, wait N2s,N2After the preferred 3-8s. of s is waited, start drain, discharge
Redundancy measures V1, until liquid measure is equal to metering needed for targeted injection in syringe, then stops drain, and automatic load terminates.
The above shows and describes the basic principles and main features of the present invention and the advantages of the present invention.The technology of the industry
Personnel are it should be appreciated that the present invention is not limited to the above embodiments, and the above embodiments and description only describe this
The principle of invention, without departing from the spirit and scope of the present invention, various changes and improvements may be made to the invention, these changes
Change and improvement all fall within the protetion scope of the claimed invention.The claimed scope of the invention by appended claims and its
Equivalent thereof.
Claims (3)
1. a kind of automatic pipetting systems of syringe, it is characterised in that: structure includes: early-stage preparations system and inhales medicine system, described
Early-stage preparations system sets different automatic imbibition capacity V, and preferably automated imbibition capacity V is between 20-40ml, pricker
The preferred capacity of imbibition is between 5-15ml；The pipetting systems are divided into two stage systems, and the first stage is emptying system,
Second stage is quantitative system.
2. the automatic pipetting systems of a kind of syringe according to claim 1, it is characterised in that: the first stage emptying
System is: using key or touch screen, start-up loading function, syringe starts imbibition, when institute's liquid absorption amount is equal to early-stage preparations
When the automatic imbibition capacity V of section sets, syringe stops imbibition, waiting time NOs,NOThe preferred 0.5-3s of s, then starts
Drain judges whether there is air in syringe, if stopping drain, then waiting time N without air in syringe1S, N1S is excellent
Select 0.5-3s.
3. the automatic pipetting systems of a kind of syringe according to claim 1, it is characterised in that: the second stage is quantitative
System is: syringe imbibition, measures V1 plus redundancy when the liquid measure sucked in syringe reaches metering needed for preset targeted injection,
Redundancy measures the preferred 5-20ml of V1, and syringe stops imbibition, waits N2s,N2After the preferred 3-8s. of s is waited, start drain, row
Redundancy measures V1 out, until liquid measure is equal to metering needed for targeted injection in syringe, then stops drain.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710733249.7A CN109420214A (en) | 2017-08-24 | 2017-08-24 | A kind of automatic pipetting systems of syringe |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710733249.7A CN109420214A (en) | 2017-08-24 | 2017-08-24 | A kind of automatic pipetting systems of syringe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109420214A true CN109420214A (en) | 2019-03-05 |
Family
ID=65500883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710733249.7A Pending CN109420214A (en) | 2017-08-24 | 2017-08-24 | A kind of automatic pipetting systems of syringe |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109420214A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1901952A (en) * | 2003-12-31 | 2007-01-24 | 马林克罗特公司 | Contrast container holder and method to fill syringes |
| CN101518662A (en) * | 2004-02-17 | 2009-09-02 | 利布尔-弗拉希姆公司 | Injector auto purge |
-
2017
- 2017-08-24 CN CN201710733249.7A patent/CN109420214A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1901952A (en) * | 2003-12-31 | 2007-01-24 | 马林克罗特公司 | Contrast container holder and method to fill syringes |
| CN101518662A (en) * | 2004-02-17 | 2009-09-02 | 利布尔-弗拉希姆公司 | Injector auto purge |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hajarizadeh et al. | Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis | |
| CN205729962U (en) | A kind of gynaecologic vaginal medicine-feeding administrator | |
| Nelson et al. | Immunogenicity of human papillomavirus recombinant vaccine in children with CKD | |
| Awad et al. | An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) in adults receiving hemodialysis | |
| Fernando et al. | Safety, tolerability and pharmacokinetics of single doses of oxytocin administered via an inhaled route in healthy females: randomized, single-blind, phase 1 study | |
| Murray et al. | Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial | |
| Cagiran et al. | Comparison of oral Midazolam and Midazolam-Ketamine as sedative agents in paediatric dentistry. | |
| Stote et al. | Enhanced absorption of Nasulin™, an ultrarapid-acting intranasal insulin formulation, using single nostril administration in normal subjects | |
| Cheong et al. | Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection | |
| CN109420214A (en) | A kind of automatic pipetting systems of syringe | |
| Hao et al. | Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy in patients with congenital hypogonadotropic hypogonadism: a multicentre clinical study | |
| CN102688238A (en) | Montelukast sodium combination drug granules for treating asthma, and application thereof | |
| CN207614057U (en) | Bull liquid absorption device | |
| Perlin et al. | CERC-002, a human anti-LIGHT MAB reduces respiratory failure and death in hospitalized COVID-19 ARDS patients | |
| Chaabane et al. | Bowel preparation before colonoscopy | |
| WO2019210547A1 (en) | Medicine pumping method based on dispensing robot and dispensing robot | |
| CN218248086U (en) | Double-cavity syringe | |
| CN201643096U (en) | Closed thoracic cavity puncture device | |
| Law et al. | Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B | |
| Göçmen et al. | The effects of add-back therapy with tibolone on myoma uteri. | |
| Castro-Rodriguez et al. | Interferon β-1a ring prophylaxis to reduce household transmission of SARS-CoV-2: a cluster randomised clinical trial | |
| CN201492423U (en) | Blood collector for infant | |
| Hutauruk et al. | Clinical Overview of Ureum Levels in Type II Diabetes Mellitus Patients Infected by COVID-19 Pandemic | |
| CN2917669Y (en) | Disposable self-destroyable syringe | |
| van Gastel et al. | Luteinizing hormone–releasing hormone receptor antagonist may reduce postmenopausal flushing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20210319 Address after: 210029 Block A, 8th Floor, 301 Hanzhongmen Street, Gulou District, Nanjing City, Jiangsu Province Applicant after: Nanjing Jusha Display Technology Co.,Ltd. Applicant after: NANJING JUSHA MEDICAL TECHNOLOGY Co.,Ltd. Address before: 210003 No.5, Hongmiao Lane 1, Fujian Road, Gulou District, Nanjing City, Jiangsu Province Applicant before: NANJING GANKONGTONG CHEMICAL PRODUCT OPERATION PORTION |
|
| TA01 | Transfer of patent application right |